Publications Database

Bishop J. R. et al. (2015)

Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.

Pharmacogenetics and Genomics

November, 25(11), pp. 548-554.

Read Abstract (New Window)

Owley T. et al. (2010)

A pharmacogenetic study of escitalopram in autism spectrum disorders.

Autism Research

3(1), pp. 1-7.

Read Abstract (New Window)

Owley T. et al. (2006)

A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 517-552

Read Abstract (New Window)

Owley T. et al. (2005)

An open-label trial of escitalopram in pervasive developmental disorders.

Journal of the American Academy of Child and Adolescent Psychiatry

44(4), pp. 343-348

Read Abstract (New Window)